补充孕激素是否会增加肝脏内胆固醇形成的风险?
Matthew C H Rohn1, Lindsey Vignali1, Isabel Reeder2
1Department of Obstetrics and Gynecology, George Washington University Hospital, Washington, District of Columbia.
American journal of perinatology
|May 7, 2024
概括
这项研究发现补充孕激素和怀孕 (ICP) 的肝脏内胆固醇形成之间没有联系. 之前的研究显示出混合的结果,可能是由于不同的孕激素配方或施用途径.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 在怀孕期间的药理学
背景情况:
- 妊娠的肝脏内胆固醇症 (ICP) 是一种严重的妊娠并发症.
- 补充孕激素在ICP发展中的作用受到辩论.
- 最近的证据表明存在潜在联系,需要进一步调查.
研究的目的:
- 评估怀孕期间补充孕激素使用与怀孕 (ICP) 肝脏内胆固醇症的发生率之间的关联.
主要方法:
- 从2012-2022年进行了一项回顾性,匹配的病例控制研究.
- 120个ICP病例与360个对照进行了匹配.
- 对ART使用和肝病史进行调整后勤回归.
主要成果:
- 病例中肝病史,多胎妊娠,先前的ICP和早期分娩的比例较高.
- 在ICP病例和对照之间没有观察到补充孕激素使用的显著差异.
- 未调整和调整的分析没有显示任何关联 (aOR=0.98,95% CI:0.24-3.94).
结论:
- 这项研究没有发现补充孕激素和ICP之间的关联.
- 风险可能取决于孕激素的配方或服用途径.
- 需要进一步的研究来澄清孕激素-ICP关系.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
160
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
160
Ovarian Cycle
1.2K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.2K
Inflammatory Bowel Disease I: Ulcerative Colitis
166
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
166
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
414
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
414
Chronic Bowel Disorders: Introduction
445
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
445
Acute Pancreatitis II: Clinical Manifestations and Management
122
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
122


